Ignite Creation Date:
2025-12-25 @ 4:46 AM
Ignite Modification Date:
2025-12-26 @ 3:47 AM
Study NCT ID:
NCT02398318
Status:
WITHDRAWN
Last Update Posted:
2016-12-06
First Post:
2015-01-23
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
China Refractory Obsessive-Compulsive Disorder Deep Brain Stimulation Study
Sponsor:
Ruijin Hospital
Organization:
Study Overview
Official Title:
China Refractory-Obsessive Compulsive Disorder Deep Brain Stimulation Study
Status:
WITHDRAWN
Status Verified Date:
2016-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
A pilot study is recruiting
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CRODS
Brief Summary:
Refractory obsessive-compulsive disorder (OCD) is a disabling condition. Deep brain stimulation (DBS) of the nucleus accumbens is the most tested therapeutic avenue for refractory OCD. However, large scale randomized controlled trials to evaluate the effectiveness of this approach are rare.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: